BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 19650077)

  • 1. Tubulin targets in the pathobiology and therapy of glioblastoma multiforme. II. gamma-Tubulin.
    Katsetos CD; Dráberová E; Legido A; Dráber P
    J Cell Physiol; 2009 Dec; 221(3):514-20. PubMed ID: 19650077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tubulin targets in the pathobiology and therapy of glioblastoma multiforme. I. Class III beta-tubulin.
    Katsetos CD; Dráberová E; Legido A; Dumontet C; Dráber P
    J Cell Physiol; 2009 Dec; 221(3):505-13. PubMed ID: 19650075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered cellular distribution and subcellular sorting of gamma-tubulin in diffuse astrocytic gliomas and human glioblastoma cell lines.
    Katsetos CD; Reddy G; Dráberová E; Smejkalová B; Del Valle L; Ashraf Q; Tadevosyan A; Yelin K; Maraziotis T; Mishra OP; Mörk S; Legido A; Nissanov J; Baas PW; de Chadarévian JP; Dráber P
    J Neuropathol Exp Neurol; 2006 May; 65(5):465-77. PubMed ID: 16772870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting βIII-tubulin in glioblastoma multiforme: from cell biology and histopathology to cancer therapeutics.
    Katsetos CD; Draber P; Kavallaris M
    Anticancer Agents Med Chem; 2011 Oct; 11(8):719-28. PubMed ID: 21707498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging microtubule targets in glioma therapy.
    Katsetos CD; Reginato MJ; Baas PW; D'Agostino L; Legido A; Tuszyn Ski JA; Dráberová E; Dráber P
    Semin Pediatr Neurol; 2015 Mar; 22(1):49-72. PubMed ID: 25976261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PACSIN proteins bind tubulin and promote microtubule assembly.
    Grimm-Günter EM; Milbrandt M; Merkl B; Paulsson M; Plomann M
    Exp Cell Res; 2008 Jun; 314(10):1991-2003. PubMed ID: 18456257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microtubules: a dynamic target in cancer therapy.
    Pasquier E; Kavallaris M
    IUBMB Life; 2008 Mar; 60(3):165-70. PubMed ID: 18380008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Designer therapies for glioblastoma multiforme.
    Sathornsumetee S; Rich JN
    Ann N Y Acad Sci; 2008 Oct; 1142():108-32. PubMed ID: 18990124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Class III beta-tubulin and gamma-tubulin are co-expressed and form complexes in human glioblastoma cells.
    Katsetos CD; Dráberová E; Smejkalová B; Reddy G; Bertrand L; de Chadarévian JP; Legido A; Nissanov J; Baas PW; Dráber P
    Neurochem Res; 2007 Aug; 32(8):1387-98. PubMed ID: 17406983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beyond grade: molecular pathology of malignant gliomas.
    Sulman EP; Guerrero M; Aldape K
    Semin Radiat Oncol; 2009 Jul; 19(3):142-9. PubMed ID: 19464628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 15-Deoxi-Delta(12,14)-prostaglandin J2 is a tubulin-binding agent that destabilizes microtubules and induces mitotic arrest.
    Cocca C; Dorado J; Calvo E; López JA; Santos A; Perez-Castillo A
    Biochem Pharmacol; 2009 Nov; 78(10):1330-9. PubMed ID: 19576185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MUBPy is a novel centrosome-associated protein and interacts with gamma-tubulin.
    Berruti G; Aivatiadou E
    J Submicrosc Cytol Pathol; 2006 Apr; 38(1):77-83. PubMed ID: 17283968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidermal growth factor receptor variant III-induced glioma invasion is mediated through myristoylated alanine-rich protein kinase C substrate overexpression.
    Micallef J; Taccone M; Mukherjee J; Croul S; Busby J; Moran MF; Guha A
    Cancer Res; 2009 Oct; 69(19):7548-56. PubMed ID: 19773446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II study of neoadjuvant imatinib in glioblastoma: evaluation of clinical and molecular effects of the treatment.
    Razis E; Selviaridis P; Labropoulos S; Norris JL; Zhu MJ; Song DD; Kalebic T; Torrens M; Kalogera-Fountzila A; Karkavelas G; Karanastasi S; Fletcher JA; Fountzilas G
    Clin Cancer Res; 2009 Oct; 15(19):6258-66. PubMed ID: 19789313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A fraction of Crm1 locates at centrosomes by its CRIME domain and regulates the centrosomal localization of pericentrin.
    Liu Q; Jiang Q; Zhang C
    Biochem Biophys Res Commun; 2009 Jul; 384(3):383-8. PubMed ID: 19422798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding the origins of gliomas and developing novel therapies: cerebrospinal fluid and subventricular zone interplay.
    Glantz M; Kesari S; Recht L; Fleischhack G; Van Horn A
    Semin Oncol; 2009 Aug; 36(4 Suppl 2):S17-24. PubMed ID: 19660679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The pattern of centriole immunostaining for tyrosinated or acetylated alpha-tubulin changes during mitosis in 3T3 (A31) cells but not in SV40-3T3 cells].
    Balashova EE; Lokhov PG; Bystrevskaia VB
    Tsitologiia; 2009; 51(6):511-9. PubMed ID: 19637755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DIXDC1 co-localizes and interacts with gamma-tubulin in HEK293 cells.
    Wu Y; Jing X; Ma X; Wu Y; Ding X; Fan W; Fan M
    Cell Biol Int; 2009 Jun; 33(6):697-701. PubMed ID: 19375513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical detection of class III beta-tubulin in primary brain tumours: variable expression in most tumour types limits utility as a differential diagnostic marker.
    Laggner U; Pipp I; Budka H; Hainfellner JA; Preusser M
    Histopathology; 2007 Jun; 50(7):949-52. PubMed ID: 17543088
    [No Abstract]   [Full Text] [Related]  

  • 20. Structure-activity and high-content imaging analyses of novel tubulysins.
    Wang Z; McPherson PA; Raccor BS; Balachandran R; Zhu G; Day BW; Vogt A; Wipf P
    Chem Biol Drug Des; 2007 Aug; 70(2):75-86. PubMed ID: 17683369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.